VERACYTE, INC. (VCYT) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001384101 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $150.3M | $25.5M | $0.31 | Filing |
| Mar 31, 2026 | May 5, 2026 | $139.1M | $28.7M | $0.35 | Filing |
| Dec 31, 2025 | Jan 12, 2026 | $140.6M | $41.2M | $0.50 | Filing |
| Sep 30, 2025 | Nov 4, 2025 | $131.9M | $19.1M | $0.24 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $130.2M | $-980,000 | $-0.01 | Filing |
| Mar 31, 2025 | May 7, 2025 | $114.5M | $7.0M | $0.09 | Filing |
| Dec 31, 2024 | Feb 24, 2025 | $118.6M | $5.1M | $0.07 | Filing |
| Sep 30, 2024 | Nov 6, 2024 | $115.9M | $15.2M | $0.19 | Filing |
What would VERACYTE, INC. have to report for its valuation to change?
At $44.39, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 22.1% a year, to $3.79. On that path the next quarter needs diluted EPS near $0.29, against $0.24 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 22.1% | 22.1% |
| EPS needed in final year | $3.79 | $3.79 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. VCYT goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.